Chronic Kidney Disease in Children (CKiD) U25 eGFR Calculator
Estimates glomerular filtration rate based on combinations of creatinine, cystatin C & characteristics; ages 1-25 years.
CreatorDr. Christopher B. Pierce, MHSInstructions
Using both creatinine and cystatin C may provide a more accurate GFR estimate as it averages the results from both equations.
Serum creatinine levels can be influenced by malnutrition, decreased muscle mass, and certain medications. Cystatin C may be preferable in such cases.
The creatinine-based estimate requires sex, age, height and serum creatinine
The cystatin C-based estimate requires sex, age, and cystatin C
The combined estimate requires sex, age, height, serum creatinine and cystatin C.
Introduction
The CKiD U25 equations estimate kidney function (glomerular filtration rate, or GFR) in children, teenagers, and young adults aged 1 to 25. They were developed by researchers from the Chronic Kidney Disease in Children (CKiD) study, led by Christopher Pierce and colleagues, and published in 2021. They update the widely used 2009 “bedside Schwartz” equation. According to the study team, the data used to develop the bedside equation came mainly from children aged 8 to 15, with too few young children under five and young adults 18 and over. The U25 equations fix this by allowing the calculation to change with age and sex. They are supported for clinical use by the current 2024 KDIGO guidelines.
How it’s calculated
There are three equations, depending on which labs are available. Each uses a factor, K, that changes with the patient’s age and sex.
The creatinine-based estimate requires sex, age, height and serum creatinine
The cystatin C-based estimate requires sex, age, and cystatin C
The combined estimate requires sex, age, height, serum creatinine and cystatin C.
Results appear based on selection of the equation desired.
Results
CKiD U25 Creatinine: eGFR = k × (height, m / sCr, mg/dL)
For males, k is calculated as:
Age 1 to <12 years old: 39.0 × 1.008(age-12)
Age 12 to <18 years old: 39.0 × 1.045(age-12)
Age 18 to 25 years old: 50.8
For females, k is calculated as:
Age 1 to <12 years old: 36.1 × 1.008(age-12)
Age 12 to <18 years old: 36.1 × 1.023(age-12)
Age 18 to 25 years old: 41.4
CKiD U25 Cystatin C: eGFR = k × (1 / cysC, mg/L)
For males, k is calculated as:
Age 1 to <15 years old: 87.2 × 1.011(age-15)
Age 15 to <18 years old: 87.2 × 0.96(age-15)
Age 18 to 25 years old: 77.1
For females, k is calculated as:
Age 1 to <12 years old: 79.9 × 1.004(age-12)
Age 12 to <18 years old: 79.9 × 0.974(age-12)
Age 18 to 25 years old: 68.3
CKiD U25 Creatinine-Cystatin C: eGFR = (sCr-based eGFR + cycC-based eGFR) / 2
Management Considerations
Using both creatinine and cystatin C may provide a more accurate GFR estimate as it averages the results from both equations.
Serum creatinine levels can be influenced by malnutrition, decreased muscle mass, and certain medications. Cystatin C may be preferable in such cases.
May underestimate GFR in patients with normal renal function, particularily for cystatin C equations.
Refer to the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease (CKD) for management of CKD.
All questions & possible results
Equation OptionsTitle not visible
New question
Select one option:
- CKiD U25 Creatinine
- CKiD U25 Cystatin C
- CKiD U25 Creatinine-Cystatin C
Patient and laboratory valuesTitle not visible
Age
A number between 1 and 25, in years.
Sex
Select one option:
- Male
- Female
Height
A number between 0.4 and 300, in cm or in.
Serum creatinine
Normal Range:
0.7-1.3 mg/dL
62-115 μmol/L
A number between 0.05 and 500, in mg/dL or μmol/L.
Cystatin C
Normal Range: 0.51-0.98 mg/L
A number between 0.05 and 20.01, in mg/L.
Possible results
CKiD U25 Creatinine eGFR
May underestimate GFR in patients with normal renal function.
Refer to the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease (CKD) for management of CKD.
CKiD U25 Cystatin C eGFR
May underestimate GFR in patients with normal renal function, particularily for cystatin C equations.
Refer to the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease (CKD) for management of CKD.
CKiD U25 Creatinine-Cystatin C eGFR
May underestimate GFR in patients with normal renal function, particularily for cystatin C equations.
Refer to the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease (CKD) for management of CKD.
Citation
Pierce CB, Muñoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ. Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int. 2021 Apr;99(4):948-956.
Literature
Pierce CB, Muñoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ. Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int. 2021 Apr;99(4):948-956.
https://pubmed.ncbi.nlm.nih.gov/33301749/Ng DK, Furth SL, Warady BA, Crews DC, Seegmiller JC, Schwartz GJ; CKiD Study Investigators. Self-reported Race, Serum Creatinine, Cystatin C, and GFR in Children and Young Adults With Pediatric Kidney Diseases: A Report From the Chronic Kidney Disease in Children (CKiD) Study. Am J Kidney Dis. 2022 Aug;80(2):174-185.e1.
https://pubmed.ncbi.nlm.nih.gov/34974031/Ibrahim RB, Srivaths P, Tam E, Devaraj S. Utility of Cystatin C-based Equation for the Estimation of Glomerular Filtration Rate in a Pediatric Population. J Appl Lab Med. 2024 Jul 1;9(4):803-808.
https://pubmed.ncbi.nlm.nih.gov/38656545/Atkinson MA, Ng DK, Warady BA, Furth SL, Flynn JT. The CKiD study: overview and summary of findings related to kidney disease progression. Pediatr Nephrol. 2021 Mar;36(3):527-538.
https://pubmed.ncbi.nlm.nih.gov/32016626/
- CreatorDr. Christopher B. Pierce, MHSResearch associate at the Johns Hopkins Bloomberg School of Public Health department of epidemiology.
- Provided by
EVAL Foundation
- Contributor · Reviewer
Jennifer Glen, DNP, FNP-BCEVAL Health, Chief Medical Officer EVAL Foundation